Spatial variations in STIs among women enrolled in HIV prevention clinical trials in Durban, KwaZulu-Natal, South Africa.


Journal

SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance
ISSN: 1813-4424
Titre abrégé: SAHARA J
Pays: South Africa
ID NLM: 101226212

Informations de publication

Date de publication:
12 2023
Historique:
medline: 3 4 2023
entrez: 30 3 2023
pubmed: 31 3 2023
Statut: ppublish

Résumé

South Africa is faced with a high HIV and STI prevalence and incidence, respectively, with pockets of high burden areas driving these diseases. Localised monitoring of the HIV epidemic and STI endemic would enable more effective targeted prevention strategies. We assessed spatial variations in curable STI incidence among a cohort of women enrolled in HIV prevention clinical trials between 2002 and 2012. STI incidence rates from 7557 South African women enrolled in five HIV prevention trials were geo-mapped using participant household GPS coordinates. Age and period standardised incidence rates were calculated for 43 recruitment areas and Bayesian conditional autoregressive areal spatial regression (CAR) was used to identify significant patterns and spatial patterns of STI infections in recruitment communities. Overall age and period standardised STI incidence rate were estimated as 15 per 100 PY and ranged from 6 to 24 per 100 PY. We identified five significant STI high risk areas with higher-than-expected incidence of STIs located centrally (three-locations) and southern neighbouring areas of Durban (two-locations). Younger age (<25), not married/cohabitating, parity <3 and poor education were all significant correlates of high STI communities. Findings demonstrate sustained STI incidence rates across the greater Durban area. The role of STI incidence in HIV acquisition in high HIV endemic areas need to be revisited as current highly effective PrEP interventions do not protect from STI acquisition. In these settings there is an urgent need for integrative HIV and STI prevention and treatment services.

Identifiants

pubmed: 36995287
doi: 10.1080/17290376.2023.2193238
pmc: PMC10064823
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2193238

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI069469
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI048008
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069422
Pays : United States

Références

Sex Transm Dis. 1998 Jan;25(1):20-3
pubmed: 9437780
AIDS. 2016 Nov 13;30(17):2665-2683
pubmed: 27500670
J Infect Dis. 2008 Mar 1;197(5):728-32
pubmed: 18260766
PLoS One. 2018 Oct 15;13(10):e0205863
pubmed: 30321236
Lancet. 2019 Jul 27;394(10195):303-313
pubmed: 31204114
N Engl J Med. 2007 Feb 22;356(8):790-9
pubmed: 17314338
J Adv Nurs. 2007 Nov;60(4):377-83
pubmed: 17822425
AIDS Behav. 2014 Feb;18(2):317-22
pubmed: 23934268
Biometrics. 1990 Dec;46(4):1171-8
pubmed: 2085632
AIDS. 2011 Apr 24;25(7):957-66
pubmed: 21330907
BMJ Open. 2020 Apr 8;10(4):e034476
pubmed: 32273314
J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):333-9
pubmed: 15980695
Lancet. 2010 Oct 16;376(9749):1329-37
pubmed: 20851460
N Engl J Med. 2015 Feb 5;372(6):509-18
pubmed: 25651245
Nature. 2019 Jun;570(7760):189-193
pubmed: 31092927
PLoS Med. 2015 Jan 22;12(1):e1001778
pubmed: 25612136
Epidemiol Infect. 2005 Jun;133(3):421-8
pubmed: 15962548
Bull World Health Organ. 2019 Aug 01;97(8):548-562P
pubmed: 31384073
PLoS One. 2016 Apr 22;11(4):e0153969
pubmed: 27104835
BMC Infect Dis. 2019 Jun 7;19(1):500
pubmed: 31174475
Bull World Health Organ. 2013 Mar 1;91(3):174-83
pubmed: 23476090
PLoS Med. 2018 Feb 27;15(2):e1002511
pubmed: 29485986
PLoS Med. 2018 Feb 27;15(2):e1002512
pubmed: 29485985
AIDS. 2007 Dec;21 Suppl 8:S53-7
pubmed: 18172392
Lancet. 2007 Jul 21;370(9583):251-261
pubmed: 17631387
Lancet Infect Dis. 2019 Oct;19(10):1091-1100
pubmed: 31416692
J Infect Dis. 2018 Oct 20;218(11):1759-1766
pubmed: 29947802
Sex Transm Dis. 2010 Jul;37(7):460-6
pubmed: 20562586
Sex Transm Infect. 2005 Aug;81(4):287-93
pubmed: 16061532
BMC Infect Dis. 2019 Oct 28;19(1):902
pubmed: 31660883
Sex Transm Infect. 2011 Apr;87(3):183-90
pubmed: 21330572
PLoS One. 2012;7(4):e35278
pubmed: 22536364
AIDS. 2010 Oct;24 Suppl 4:S15-26
pubmed: 21042049
Am J Public Health. 1992 May;82(5):669-74
pubmed: 1566944
Lancet. 2008 Dec 6;372(9654):1977-87
pubmed: 19059048
Sex Transm Dis. 1992 Mar-Apr;19(2):61-77
pubmed: 1595015

Auteurs

Reshmi Dassaye (R)

HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa.

Handan Wand (H)

Kirby Institute, University of New South Wales, Kensington, Australia.

Tarylee Reddy (T)

Biostatistics Unit, South African Medical Research Council, Durban, South Africa.

Frank Tanser (F)

University of Lincoln, Lincoln Institute for Health, Lincoln, UK.

Benn Sartorius (B)

Faculty of Infectious and Tropical Diseases (ITD), London School of Hygiene & Tropical Medicine, London, UK.

Natashia Morris (N)

Biostatistics Unit: GIS, South African Medical Research Council, Durban, South Africa.

Gita Ramjee (G)

HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa.
London School of Hygiene and Tropical Medicine, Department of Epidemiology and Population Health, London, UK.
School of Medicine, Department of Global Health, University of Washington, Seattle, WA, USA.
The Aurum Institute, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH